Literature DB >> 15945098

Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells.

Shigeo Koido1, Eiichi Hara, Akira Torii, Sadamu Homma, Yoichi Toyama, Hidejiro Kawahara, Masaichi Ogawa, Michiaki Watanabe, Katsuhiko Yanaga, Kiyotaka Fujise, Jianlin Gong, Gotaro Toda.   

Abstract

Human metastatic colorectal carcinomas (CRCAs) express carcinoembryonic antigen (CEA) and/or MUC1 tumor-associated antigens as potential targets for the induction of active specific immunity. In the present study, freshly isolated metastatic CRCA cells were successfully fused with immature autologous human monocyte-derived dendritic cells (DCs). The created heterokaryons (DC/CRCA) coexpress the CRCA-derived CEA and MUC1 antigens and DC-derived MHC class II and costimulatory molecules. The fusion cells were functional in stimulating the proliferation of autologous T cells. In addition, both CD4(+) and CD8(+) T cells were activated by fusion cells, as demonstrated by the production of high levels of IFN-gamma. More importantly, coculture of fusion cells with patient-derived peripheral blood mononuclear cells (PBMCs) resulted in the induction of antigen-specific cytotoxic T lymphocytes (CTLs). CTLs were effective at lysis of not only autologous CRCA cells but also the CEA and/or MUC1-positive and HLA partially matched target cells. Antigen-specific CTL responses were confirmed by tetrameric analysis. Coculture of PBMCs with fusion cells resulted in increased frequency of CEA- and MUC1-specific CTLs simultaneously. Taken together, these results indicate that freshly isolated human metastatic CRCA cells expressing the CEA and/or MUC1 may represent a potential partner for the creation of DC/tumor fusion cells targeting induction of antigen-specific CTL responses. Our report demonstrates the simultaneous induction of CRCA-specific CTL responses restricted by HLA-A2 and -A24. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15945098     DOI: 10.1002/ijc.21184

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

Review 1.  Cancer vaccine by fusions of dendritic and cancer cells.

Authors:  Shigeo Koido; Eiichi Hara; Sadamu Homma; Yoshihisa Namiki; Toshifumi Ohkusa; Jianlin Gong; Hisao Tajiri
Journal:  Clin Dev Immunol       Date:  2010-02-18

Review 2.  Pattern response of dendritic cells in the tumor microenvironment and breast cancer.

Authors:  Alessandra da Cunha; Marcia A Michelin; Eddie Fc Murta
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Antigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cells.

Authors:  Shigeo Koido; Sadamu Homma; Eiichi Hara; Yoshihisa Namiki; Toshifumi Ohkusa; Jianlin Gong; Hisao Tajiri
Journal:  J Biomed Biotechnol       Date:  2010-04-07

4.  Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates.

Authors:  Yannick Simoni; Etienne Becht; Michael Fehlings; Chiew Yee Loh; Si-Lin Koo; Karen Wei Weng Teng; Joe Poh Sheng Yeong; Rahul Nahar; Tong Zhang; Hassen Kared; Kaibo Duan; Nicholas Ang; Michael Poidinger; Yin Yeng Lee; Anis Larbi; Alexis J Khng; Emile Tan; Cherylin Fu; Ronnie Mathew; Melissa Teo; Wan Teck Lim; Chee Keong Toh; Boon-Hean Ong; Tina Koh; Axel M Hillmer; Angela Takano; Tony Kiat Hon Lim; Eng Huat Tan; Weiwei Zhai; Daniel S W Tan; Iain Beehuat Tan; Evan W Newell
Journal:  Nature       Date:  2018-05-16       Impact factor: 49.962

Review 5.  Immunotherapy for colorectal cancer.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Sadamu Homma; Yoshihisa Namiki; Kazuki Takakura; Keisuke Saito; Zensho Ito; Hiroko Kobayashi; Mikio Kajihara; Kan Uchiyama; Seiji Arihiro; Hiroshi Arakawa; Masato Okamoto; Jianlin Gong; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 6.  Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.

Authors:  Shigeo Koido; Sadamu Homma; Akitaka Takahara; Yoshihisa Namiki; Hideo Komita; Eijiro Nagasaki; Masaki Ito; Keisuke Nagatsuma; Kan Uchiyama; Kenichi Satoh; Toshifumi Ohkusa; Jianlin Gong; Hisao Tajiri
Journal:  J Biomed Biotechnol       Date:  2011-04-26

Review 7.  Regulation of tumor immunity by tumor/dendritic cell fusions.

Authors:  Shigeo Koido; Sadamu Homma; Eiichi Hara; Yoshihisa Namiki; Akitaka Takahara; Hideo Komita; Eijiro Nagasaki; Masaki Ito; Toshifumi Ohkusa; Jianlin Gong; Hisao Tajiri
Journal:  Clin Dev Immunol       Date:  2010-10-26

8.  In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.

Authors:  Shigeo Koido; Sadamu Homma; Eiichi Hara; Makoto Mitsunaga; Yoshihisa Namiki; Akitaka Takahara; Eijiro Nagasaki; Hideo Komita; Yukiko Sagawa; Toshifumi Ohkusa; Kiyotaka Fujise; Jianlin Gong; Hisao Tajiri
Journal:  J Transl Med       Date:  2008-09-15       Impact factor: 5.531

9.  Immunological suppression of head and neck carcinoma by dendritic cell tumor fusion vaccine.

Authors:  Yongbin Mou; Hao Xie; Xiaofeng Huang; Wei Han; Yanhong Ni; Hang Su; Zhiyong Wang; Qingang Hu
Journal:  Oncol Lett       Date:  2013-10-15       Impact factor: 2.967

10.  A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy.

Authors:  Seung Jun Lee; Sung Jae Shin; Moon Hee Lee; Min-Goo Lee; Tae Heung Kang; Won Sun Park; Byoung Yul Soh; Jung Hee Park; Yong Kyoo Shin; Han Wool Kim; Cheol-Heui Yun; In Duk Jung; Yeong-Min Park
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.